Search

Rhegmatogenous retinal detachment(RRD)is the separation of the retinal nerve sensory layer and the pigment epithelium layer caused by retinal tears. It is a kind of ophthalmic emergency. If it is not treated in time, the blinding rate is close to 100%. Surgery is an important way to treat RRD. With the deepening of disease awareness and the improvement of retinal reattachment techniques, RRD reattachment has achieved a higher anatomical success rate, but in clinical, the postoperative visual experience of patients is still not ideal. This article mainly summarizes the influencing factors of RRD visual function prognosis and provides guidance for clinical treatment.

AIM: To explore the effect of vitreous macular adhesion(VMA)on the efficacy of anti-VEGF therapy in patients with branch retinal vein occlusion(BRVO).METHODS: Retrospective case study. According to initially diagnosed OCT characteristics, 110 patients(110 eyes), selected from those who received intravitreal injection of Conbercept in the ophthalmology department of our hospital from January 2017 to May 2019,were divided into VMA-present group(VMA+ group, 34 eyes)and VMA-free group(VMA- group, 76 eyes). After the first injection, at least 6mo follow-up was ensured, to record the number of injection and to examine the best corrected visual acuity(BCVA)and central macular thickness(CMT). And it's via the OCT reports to evaluate status of the vitreous macular adhesion and the occurrence of posterior vitreous detachment(PVD).RESULTS: During the 6mo follow-up after the first injection, there was no difference in the average number of intravitreal injections between patients in VMA+ group and VMA- group(2.91±1.05 times vs 3.08±1.22 times, P=0.915). At the 6mo after the first injection, BCVA and CMT were significantly improved in both groups, and BCVA gain in VMA+ group was more obvious than that in VMA- group \〖-0.20(-0.33, -0.10)LogMAR vs -0.20(-0.30, -0.10), P=0.041\〗, but there was no difference in CMT changes between the two groups(P=0.914). During this follow-up period, in the VMA+ group, 3 eyes, which were focal VMA at baseline, all developed into macular PVD(100.0%); and 5 of 31 eyes, which were extensive VMA at baseline, developed into macular PVD(16.1%). Compared with the extensive VMA, PVD was more likely to develop into focal VMA(P=0.009).CONCLUSION: BRVO patients combined with VMA have greater potentiality in visual improvements under anti-VEGF treatments. Therefore, the presence of VMA does not prevent BRVO patients from receiving anti-VEGF therapy.

AIM: To evaluate the visual outcome of Oculentis Mplus intraocular lens(IOL).METHODS: Totally 20 eyes in 20 patients received phacoemulsification and Oculentis Mplus intraocular lens implantation were as test group, and 20 eyes(Aspira-aA IOL)were as control group. The following postoperative examinations were performed after operation for 3mo: uncorrected visual acuity of distance and near, refractive results, UBM examination, the rate of wearing spectacles and the complications. RESULTS: At 3mo after surgery, distance visual acuity of test group with Oculentis Mplus IOL were 0.10±0.03,the difference with control group was not significant(t=1.74, P>0.05). Eyes in test group had an uncorrected near acuity 0.11±0.04, the difference with control group was significant(t=15.53, PCONCLUSION: The implantation of Oculentis Mplus IOL not only has a good distance uncorrected visual acuity, but also with better near visual acuity. The surgery is safe, reliable and no special complication induced.

AIM:To observe the clinical efficacy of phacoemulsification combined with goniosynechialysis for chronic angle-closure glaucoma with cataract. METHODS:Fifty eyes in 50 patients with chronic angle-closure glaucoma and cataract, but without complications underwent phacoemulsification and intraocular lens(IOL)implantation, combined with goniosynechialysis. All patients were followed up for 3mo. The best corrected visual acuity(BCVA), intraocular pressure(IOP), anterior chamber depth and angle were recorded and compared between pre-operation and post-operation. The results were showed by means plus or subtracting deviation standard. The BCVA, IOP, anterior chamber depth and angle were analysed by t test. RESULTS:The best corrected visual acuity at 3mo after operations was significantly higher than that before operations(t=8.76, P=0.001). The IOP at 3mo after operations was 15.63±3.11mmHg and was significantly lower than that(45.12±5.30mmHg)before operations(t=6.27, P=0.000). The anterior chamber depth at 3mo after operations was 3.57±0.02mm, and was significantly deeper than that(1.43±0.25mm)before operations(t=8.16, P=0.001). Compared with preoperative anterior chamber angle, those after operations were wider(Z=-4.432,P=0.000; Z=-2.432,P=0.016; Z=-4.379,P=0.000; Z=-4.538,P=0.000).CONCLUSION:Phacoemulsification combined with goniosynechialysis is safe and effective for chronic angle-closure glaucoma with cataract, which can control IOP and improve the visual acuity.